Cullinan Oncology Inc at Needham Healthcare Conference (Virtual) Transcript - Thomson StreetEvents

Cullinan Oncology Inc at Needham Healthcare Conference (Virtual) Transcript

Cullinan Oncology Inc at Needham Healthcare Conference (Virtual) Transcript - Thomson StreetEvents
Cullinan Oncology Inc at Needham Healthcare Conference (Virtual) Transcript
Published Apr 13, 2022
Published Apr 13, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CGEM.OQ presentation 13-Apr-22 12:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Cullinan Oncology Inc
Ticker
CGEM.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Gil Blum - Needham & Company, LLC - Analyst : Thank you, Jeff. Maybe just a couple here. So I know you touched upon this briefly, but Cullinan has a very broad portfolio of programs. So maybe they go across different therapeutic strategies, right, from targeted therapeutics, immuno-oncology. Is there a guiding principle? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. APRIL 13, 2022 / 12:00PM, CGEM.OQ - Cullinan Oncology Inc at Needham Healthcare Conference (Virtual)


Question: Gil Blum - Needham & Company, LLC - Analyst : Great. That's very helpful. And about your EGFR program, let's look -- let's assume that everything goes well, where do you expect this molecule to fit in within the competitive landscape? I mean there's quite a few EGFR mutant-targeting drugs.


Question: Gil Blum - Needham & Company, LLC - Analyst : That's very helpful. And maybe a last one on your cytokine program. This is a little bit of a broader question. So there's been a lot of -- how shall we say -- not the most positive news. And attitudes in the market are not great when it comes to cytokines. I understand IL-12 is different, and every program is born differently. But what do you say is your messaging there?


Question: Gil Blum - Needham & Company, LLC - Analyst : All right. Excellent. Thank you so much, Jeff, for presenting today for Cullinan. And we look forward to seeing your progress.

Table Of Contents

Cullinan Oncology Inc at Stifel Targeted Oncology Days (Virtual) Transcript – 2023-04-26 – US$ 54.00 – Edited Transcript of CGEM.OQ presentation 26-Apr-23 6:30pm GMT

Cullinan Oncology Inc To Discuss About Licensing Agreement with Harbour Biomed Transcript – 2023-02-14 – US$ 54.00 – Edited Transcript of CGEM.OQ conference call or presentation 14-Feb-23 1:00pm GMT

Cullinan Oncology Inc at Credit Suisse Healthcare Conference Transcript – 2022-11-08 – US$ 54.00 – Edited Transcript of CGEM.OQ presentation 8-Nov-22 6:25pm GMT

Cullinan Oncology Inc at Morgan Stanley Global Healthcare Conference Transcript – 2022-09-14 – US$ 54.00 – Edited Transcript of CGEM.OQ presentation 14-Sep-22 2:35pm GMT

Taiho To Acquire Cullinan Oncology’s Subsidiary, Cullinan Pearl - M&A Call Transcript – 2022-05-12 – US$ 54.00 – Edited Transcript of CGEM.OQ M&A conference call or presentation 12-May-22 12:00pm GMT

Cullinan Oncology Inc To Host CLN-081 Regulatory Update Webinar Transcript – 2022-03-28 – US$ 54.00 – Edited Transcript of CGEM.OQ conference call or presentation 28-Mar-22 8:30pm GMT

Cullinan Oncology Inc at Barclays Global Healthcare Conference Transcript – 2022-03-16 – US$ 54.00 – Edited Transcript of CGEM.OQ presentation 16-Mar-22 7:20pm GMT

Cullinan Oncology Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-13 – US$ 54.00 – Edited Transcript of CGEM.OQ presentation 13-Jan-22 12:30pm GMT

Cullinan Oncology Inc To Provide CLN-081 Clinical Update Webinar Call Transcript – 2021-12-16 – US$ 54.00 – Edited Transcript of CGEM.OQ conference call or presentation 16-Dec-21 1:00pm GMT

Cullinan Oncology Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-13 – US$ 54.00 – Edited Transcript of CGEM.OQ presentation 13-Sep-21 4:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Cullinan Oncology Inc at Needham Healthcare Conference (Virtual) Transcript" Apr 13, 2022. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Cullinan-Oncology-Inc-at-Needham-Healthcare-Conference-Virtual-T15171796>
  
APA:
Thomson StreetEvents. (2022). Cullinan Oncology Inc at Needham Healthcare Conference (Virtual) Transcript Apr 13, 2022. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Cullinan-Oncology-Inc-at-Needham-Healthcare-Conference-Virtual-T15171796>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.